Handling Changes and Variations

6/7 November 2024, Barcelona, Spain

Course No. 21285



Dr. Peter Bachmann

Dr. Peter Bachmann


Dr. Josef Hofer

Dr. Josef Hofer


Dr. Wilhelm Schlumbohm

Dr. Wilhelm Schlumbohm

Marieke van Dalen

Marieke van Dalen

MARA Consultancy, The Netherlands


This education course is intended to provide guidance on the provisions laid down in the EU variations regulation and the supporting guideline. You will get to know how the regulation works and you will learn about
  •  How to efficiently submit and process variations
  •  Which benefits the supporting guidelines provide and how to use them
  •  How to handle the complexity of the global supply chain
  •  How to handle changes in API manufacturing processes
  •  How to handle changes in packaging material
  •  How to manage changes in ASMFs and CEPs
  •  What is, and what is not, an established condition (EC) according to ICH Q12?
Participants will have the opportunity to choose 1 out of 2 parallel workshops dealing with
  •  Grouping of variations
  •  Classification of variations (APIs)


Since 1 January 2010 the Commission Regulation (EC) No. 1234/2008 is binding and directly applicable in all EU member states. It defines the procedure for handling variations to the terms of marketing authorisations. Article 4 of this regulation calls for detailed guidelines explaining the different categories of variations types as well as procedural questions on the documents to be submitted in each case. These Guidelines have been consolidated in one document and published as Chapter 5 of Eudralex Volume 2A (procedures for marketing authorization) in May 2013.

The variations regulation is intended to simplify the handling of the variations procedure and to provide more flexibility in the submission and processing of variations. However, the provisions are of considerable complexity and it is important for API manufacturers and the pharmaceutical industry to be well informed about the latest status of the details of the provisions about handling changes and variations.

Additionally, the final ICH Q12 Guideline for post-approval changes was published in March 2020. The guideline introduces new concepts to facilitate the management of post-approval CMC changes in a more predictable and efficient manner. The new ICH Q12 concepts include, for example, “Established Conditions” (ECs) and “Post-Approval Change Management Protocols” (PACMPs) to extent regulatory flexibility.

Finally, a lot of regulatory work (e.g. variations) needs to be managed due to the Brexit.

Target Group

The education course is designed for all persons involved in the compilation of pharmaceutical dossiers for marketing authorisations who want to become familiar with the EU variations regulation, in particular for personnel from Regulatory Affairs. Furthermore, the education course will be of interest to personnel from Quality Units, Quality Control and Production of the pharmaceutical and the API Industry.

Presentations / Certificate

The presentations for this event will be available for you to download and print before and after the event. Please note that no printed materials will be handed out on site and that there will not be any opportunity to print the presentations on site.

After the event, you will automatically receive your certificate of participation.


Handling Changes and Variations

Seminar Programme as PDF

The European Variations Procedure – an Overview
  • Introduction and legal Background
  • General provisions of the Commission Regulation (EC) No 1234/2008
  • Supporting Guidelines
  • Classification of variations
  • Procedural handling of variations
  • Grouping and worksharing of variations
  • Impact of Brexit
  • Conclusion and Expectations
Submission and Processing of Variations – the CMDh Best Practice Guides and Explanatory Notes & ICH Q12
  • Best practice guides for the processing of different types of variations
  • Best practice guides for the processing of grouped applications
  • Best practice guides on worksharing and recommendations on unforeseen variations
  • The explanatory notes on how to complete the Variation Application Form
  • ICH Q12
    • What is, and what is not, an established condition subject to post-approval change reporting requirements?
    • Expected timelines for ICH Q12 implementation
The Complexity of the Global Supply Chain
  • The global API supply chain
  • How to deal with different expectations
  • International collaboration
  • Differences between registered processes
Grouping of Variations – Case Studies
  • Cases for grouping variations according to Article 7 in connection with Annex III of the Commission Regulation
  • Possibilities to combine several changes into one single application
  • Examples
  1. Exercises for grouping of variations
  2. Exercises for classification of variations - API-related changes world wide
How to manage API Changes in a Multi-Customer Situation using ASMFs or CEPs
  • Why would you need to file a Change
  • Communication with the customers
  • Differences between ASMFs and CEPs
Handling National, European and Global Changes
  • Changes in national applications
  • Variations project Management
  • Starting and processing the notification procedure within Europe
  • Changes and variations in the US
  • Handling global changes and variations
  • Impact of Q8, Q9, Q10, Q12 and PAT
How to handle Changes in API Manufacturing Processes
  • Examples of changes
  • How to categorize a Change
  • What information to provide to whom
Variations in Packaging
  • Container closure systems of medicinal products
  • Packaging materials qualification & specification
  • Variations in drug product manufacturing
  • Regulatory documentation and strategy
ICH Q12 - Variations and Lifecycle Management
  • Reasons for Variations
  • Procedures and classifications
  • Type II Variations: time scales
  • Extension of an existing marketing authorisation
  • Categorisation of new applications versus variation applications
  • Established Conditions (ECs) and Post-Approval Change Management Protocols (PACMPs)


This course is part of the GMP Certification Programme "ECA Certified Regulatory Affairs Manager" Learn more

ECA-Member*: € 1690,-
Non ECA Member*: € 1890,-
EU/GMP Inspectorates*: € 945,-
APIC Member Discount*: € 1790,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

Further dates on-site
Further dates on-site
Not available
Further dates online
Further dates online
Not available
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023


“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024


“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024



“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023